<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02856477</url>
  </required_header>
  <id_info>
    <org_study_id>R/2007/32</org_study_id>
    <nct_id>NCT02856477</nct_id>
  </id_info>
  <brief_title>Pharmacogenetic and Antidepressant Treatment in Elderly</brief_title>
  <acronym>Pharmacogeneti</acronym>
  <official_title>Pharmacogenetic in the Therapeutic Strategy in Depressed Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to assess the therapeutic benefits of the adaptation of the antidepressant
      dose to the metabolic capacity (cytochrome P450 2D6) of elderly depressed patients.

      Therapeutic benefits are evaluated through the enhancement of efficiency, decrease of the
      action time and the after effects.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>patient remission</measure>
    <time_frame>6 months</time_frame>
    <description>remission is defined by a Montgomery and asberg depression rating (MADRS) score&lt;10.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>adapted treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the treatment dose is adapted to the metabolic capacity of the patient. intervention: urine analysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-adaptated treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the treatment dose is adapted to the metabolic capacity of the patient. intervention: urine analysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>urine analysis</intervention_name>
    <description>a sample of urine is collected during 8 hours.</description>
    <arm_group_label>adapted treatment</arm_group_label>
    <arm_group_label>non-adaptated treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  current major depressive disorder

          -  antidepressant treatment

        Exclusion Criteria:

          -  dextromethorphan contra-indication

          -  other psychiatric disorder

          -  kidney failure

          -  liver failure mini mental State Examination (MMSE)&lt;18
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>pierre Vandel, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Besancon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Besancon</name>
      <address>
        <city>Besancon</city>
        <state>Doubs</state>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 2, 2016</study_first_submitted>
  <study_first_submitted_qc>August 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2016</study_first_posted>
  <last_update_submitted>August 4, 2016</last_update_submitted>
  <last_update_submitted_qc>August 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

